SCHEMBL4924692

SCHEMBL4924692

NC[C@H](O)CCOC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.59
ALOX15 P16050 2/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
SLC6A1 P30531 1/20 0.38
TK1 P04183 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
DUT P33316 2/20 0.35
NR2E1 Q9Y466 1/20 0.34
KCNH2 Q12809 1/20 0.34
TK2 O00142 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924705 1.00 KIF11 (0.59) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL4931427 1.00 KIF11 (0.59) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL8633174 0.89 KIF11 (0.48) KIF11SLC6A1KCNH2
SCHEMBL14168221 0.82 KIF11 (0.53) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL4917240 0.82 KIF11 (0.53) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL27997026 0.82 KIF11 (0.57) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL19418904 0.79 KIF11 (0.59) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL7523027 0.79 KIF11 (0.46) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL5899878 0.79 KIF11 (0.53) KIF11ALOX15CYP2C9TSHRCYP2C19
SCHEMBL6749203 0.79 KIF11 (0.53) KIF11ALOX15CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7390825-B1 Process for the preparation of oxazolidinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2008-06-24 US disclosed
US-20080146458-A1 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2008-06-19 US disclosed
US-20070265451-A1 Process for the preparation of oxazolidinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2007-11-15 US disclosed
EP-1578723-A4 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF UNIV MICHIGAN STATE (US) 2006-11-02 EP disclosed
EP-1578723-A3 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2005-10-20 EP disclosed
EP-1578723-A2 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2005-09-28 EP disclosed
WO-2003106413-A2 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2003-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265451-A1 Process for the preparation of oxazolidinones and method of use thereof OXA1L, OTC, ODC1 KIF11 3787/4885ALOX15 1542/4885CYP2C9 108/4885
US-20080146458-A1 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF OXA1L, OGFOD1, CYP51A1 KIF11 2957/4885ALOX15 1647/4885CYP2C9 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.